Effects of the Prosegment and pH on the Activity of PCSK9-Reference-Cited by-同舟云学术

Effects of the Prosegment and pH on the Activity of PCSK9

Published:2010-12 Issue:52 Volume:285 Page:40965-40978
ISSN:0021-9258
Container-title:Journal of Biological Chemistry
language:en
Short-container-title:Journal of Biological Chemistry

Author:

Benjannet Suzanne,Luna Saavedra Yascara Grisel,Hamelin Josée,Asselin Marie-Claude,Essalmani Rachid,Pasquato Antonella,Lemaire Peter,Duke Gerald,Miao Bowman,Duclos Franck,Parker Rex,Mayer Gaétan,Seidah Nabil G.

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Biochemistry

Reference50 articles.

1. Familial hypercholesterolemia: Defective binding of lipoproteins to cultured fibroblasts associated with impaired regulation of 3-hydroxy-3-methylglutaryl coenzyme a reductase activity

2. Role of cholesterol and lipid organization in disease

3. The proprotein convertases are potential targets in the treatment of dyslipidemia

4. The secretory proprotein convertase neural apoptosis-regulated convertase 1 (NARC-1): Liver regeneration and neuronal differentiation

Cited by 63 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The role of PCSK9 in heart failure and other cardiovascular diseases—mechanisms of action beyond its effect on LDL cholesterol;Heart Failure Reviews;2024-06-18

2. PCSK9 inhibitors as safer therapeutics for atherosclerotic cardiovascular disease (ASCVD): Pharmacophore design and molecular dynamics analysis;Journal of Cellular Biochemistry;2024-05-15

3. Targeted Degradation of PCSK9 In Vivo by Autophagy-Tethering Compounds;Journal of Medicinal Chemistry;2023-12-19

4. Targeting PCSK9 to tackle cardiovascular disease;Pharmacology & Therapeutics;2023-09

5. Molecular interactions of PCSK9 with an inhibitory nanobody, CAP1 and HLA-C: Functional regulation of LDLR levels;Molecular Metabolism;2023-01